CytomX Therapeutics, Inc. (CTMX): Price and Financial Metrics
CTMX Price/Volume Stats
| Current price | $2.64 | 52-week high | $2.82 |
| Prev. close | $2.40 | 52-week low | $0.40 |
| Day low | $2.43 | Volume | 3,414,300 |
| Day high | $2.71 | Avg. volume | 3,583,274 |
| 50-day MA | $1.31 | Dividend yield | N/A |
| 200-day MA | $1.07 | Market Cap | 212.84M |
CTMX Stock Price Chart Interactive Chart >
CytomX Therapeutics, Inc. (CTMX) Company Bio
CytomX Therapeutics develops a novel class of antibody therapeutics based on its Probody technology platform that address clinically-validated cancer targets in immuno-oncology. The company was founded in 2008 and is based in San Francisco, California.
CTMX Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
CTMX Price Returns
| 1-mo | 142.20% |
| 3-mo | 297.05% |
| 6-mo | 109.52% |
| 1-year | 60.98% |
| 3-year | 38.22% |
| 5-year | -68.46% |
| YTD | 156.31% |
| 2024 | -33.55% |
| 2023 | -3.13% |
| 2022 | -63.05% |
| 2021 | -33.89% |
| 2020 | -21.18% |